Stefan Balabanov
- Molecular Biology top 5%
- Hematology top 2%
- Genetics top 2%
- Pulmonary and Respiratory Medicine top 5%
- Physiology top 5%
- Co-authors
- Tim H. BrümmendorfCarsten BokemeyerReinhard WaltherMelanie BraigChristian ScharfUlrike HartmannUwe ZimmermannSimone Venz
- Topics
- Chronic Myeloid Leukemia Treatments (22 papers)Chronic Lymphocytic Leukemia Research (17 papers)Telomeres, Telomerase, and Senescence (13 papers)
- Cited by
- HematologyGeneticsAging
- Partner nations
- GermanySwitzerlandItaly
In The Last Decade
Stefan Balabanov
95 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 111
- Molecular Biology 1.4k
- Hematology 521
- Genetics 449
- Pulmonary and Respiratory Medicine 395
- Physiology 387
Countries citing papers authored by Stefan Balabanov
This map shows the geographic impact of Stefan Balabanov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Balabanov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Balabanov more than expected).
Fields of papers citing papers by Stefan Balabanov
This network shows the impact of papers produced by Stefan Balabanov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Balabanov. The network helps show where Stefan Balabanov may publish in the future.
Co-authorship network of co-authors of Stefan Balabanov
This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Balabanov. A scholar is included among the top collaborators of Stefan Balabanov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Balabanov. Stefan Balabanov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 8 | |
| 4 | 3 | |
| 5 | 4 | |
| 6 | 7 | |
| 7 | 222 | |
| 8 | 4 | |
| 9 | 13 | |
| 10 | 12 | |
| 11 | 43 | |
| 12 | 1 | |
| 13 | 5 | |
| 14 | 9 | |
| 15 | 45 | |
| 16 | 9 | |
| 17 | 82 | |
| 18 | 54 | |
| 19 | 7 | |
| 20 | 68 |
About Stefan Balabanov
Stefan Balabanov is a scholar working on Hematology, Genetics and Nephrology, having authored 99 papers that have together received 2.8k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (22 papers), Chronic Lymphocytic Leukemia Research (17 papers) and Telomeres, Telomerase, and Senescence (13 papers). The work is most often cited by research in Hematology (521 citations), Genetics (449 citations) and Aging (46 citations). Stefan Balabanov has collaborated with scholars based in Germany, Switzerland and Italy. Frequent co-authors include Tim H. Brümmendorf, Carsten Bokemeyer, Reinhard Walther, Melanie Braig, Christian Scharf, Ulrike Hartmann, Tim H. Brümmendorf, Uwe Zimmermann, Simone Venz and Artur Gontarewicz. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.